MAIA Biotechnology

MAIA Biotechnology

  • Founded: 2018
  • Location: Chicago, IL
  • Employee range: 1 - 10
  • Clinical stage: Clin2
  • Therapy area: NSCLC
  • Drug types: ONC
  • Lead product: THIO-101 (partner: Regeneron)
  • Product link: https://maiabiotech.com/pipeline/
  • Funding: $5.75M stock Apr 2023; $10M IPO Jul 2022; $2.4M Mar 2022; $6M Oct 2021; $8M May 2021


maiabiotech.com

linkedin.com

job board


Short description:

Peptide Cancer Therapies

Drug notes:

THIO-102 Clin1 multiple cancers; THIO-103 Clin1 multiple cancers; 3 programs RD oncology

Long description:

Contact us to add description.

Jobs:


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com